NYSE:UNH News 3 January 2026 - 12 January 2026

UnitedHealth shares fell 0.8% to $343.98 Friday as senators widened their probe into the company’s nursing-home programs, citing unsatisfactory responses. Lawmakers warned they may escalate pressure if UnitedHealth does not cooperate. The company’s earnings call is set for Jan. 27. Investors are also awaiting the Jan. 13 consumer price index data.

UnitedHealth Group shares fell 2% to $341.70 in after-hours trading Wednesday, following a late-session slide. The drop came as investors weighed a possible Optum UK sale to TPG for up to $1.89 billion and awaited the company’s Jan. 27 earnings report. Peers Cigna, CVS Health, and Elevance Health also declined. U.S. job openings hit a 14-month low, further pressuring market sentiment.

UnitedHealth Group shares rose 2% to $348.97 Tuesday after Sky News reported TPG is nearing a deal to buy the insurer’s Optum UK unit for up to £1.4 billion. The report comes weeks before UnitedHealth’s Jan. 27 earnings, where it will give 2026 guidance. Talks remain tentative, with Bank of America advising and other firms interested. Optum UK includes EMIS, acquired for £1.24 billion and cleared by UK regulators in 2023.

New York, January 6, 2026, 11:46 (EST) — Regular session UnitedHealth Group shares climbed on Tuesday after a report said buyout firm TPG was closing in on a deal for the insurer’s Optum UK unit, a move investors read as another step in reshaping its health-services portfolio. The stock was up 2.1% at $349.25 by 11:30 a.m. ET. Reuters The timing matters because UnitedHealth is nearing a key reset for investors: its full-year 2025 results and 2026 guidance due later this month. The company has said it will report on Jan. 27 before the market opens and host an 8

New York, Jan 5, 2026, 18:23 EST — After-hours UnitedHealth Group Inc (UNH.N) shares rose 1.7% on Monday to $342.02, after Barclays lifted its price target on the insurer. The move matters because UnitedHealth has been a re-rating story: the stock remains far below its 52-week high and investors are looking for signs that 2026 margins can stabilize. UnitedHealth’s 52-week range is $234.60 to $606.36, underscoring how quickly sentiment has swung in the group. MarketWatch The next hard catalyst is earnings. UnitedHealth said it will release full-year 2025 results and provide 2026 financial guidance on Jan. 27 before the market

New York, Jan 3, 2026, 10:53 ET — Market closed UnitedHealth Group Incorporated shares rose 1.9% on Friday to close at $336.40, extending a New Year rebound for the Dow component after it traded between $327.50 and $340.21. The move matters now because UnitedHealth is set to deliver its next major catalyst this month: full-year 2025 results and 2026 financial guidance on Jan. 27, before the market opens, the company said. It will host a conference call at 8 a.m. ET. UnitedHealth Group The broader tape also turned positive in the first trading session of 2026, with the Dow up

NEW YORK, Jan 2, 2026, 18:00 ET — After-hours UnitedHealth Group Incorporated shares rose 1.9% to $336.40 at Friday’s close and were up about 0.2% in after-hours trading near $337.10. The stock ranged from $327.50 to $340.26 in the session as 2026 got underway. StockAnalysis The next catalyst is close. UnitedHealth will report full-year 2025 results and provide 2026 guidance on Jan. 27 before the market opens, followed by an 8 a.m. ET conference call, the company said. UnitedHealth Group That guidance lands as investors watch for signs that a tough cost cycle is easing and that the company’s operational